Skip to main content
. 2024 Jul 12;12:e17696. doi: 10.7717/peerj.17696

Figure 3. Overall survival of patients by their clinical features.

Figure 3

Patient survival by (A) HER2 expression status, (B) HR expression status, (C) TNBC, (D) number of brain lesions, (E) liver metastasis, and (F) bone metastasis. HER2, human epidermal growth factor receptor 2; HR, hormonal receptor; TNBC, triple-negative breast cancer.